Activation of the glial cells, oxidative damage, Aβ secretion, tau hyperphosphorylation, secretion of inflammatory factors, and cell loss in certain regions of the brain are unchanging or similar to the alterations observed in AD; therefore, they can lead to the development of neurodegenerative pathologies promoting AD onset and/or progression. Here, MAPT is linked to Alzheimer disease.